Antibodies against MERS Coronavirus in Dromedary Camels, Kenya, 1992–2013
Victor M. Corman
1, Joerg Jores
1, Benjamin Meyer
1, Mario Younan, Anne M. Liljander, Mohammed Y. Said, Ilona Gluecks, Erik Lattwein, Berend-Jan Bosch, Jan Felix Drexler, Set Bornstein, Christian Drosten

, and Marcel A. Müller
Author affiliations: University of Bonn Medical Centre, Bonn, Germany (V.M. Corman, B. Meyer, J.F. Drexler, C. Drosten, M.A. Müller); International Livestock Research Institute, Nairobi, Kenya (J. Jores, A. Liljander, M.Y. Said); Vétérinaires Sans Frontières Germany, Nairobi (M. Younan); Vétérinaires Sans Frontières Suisse, Nairobi (I. Gluecks); EUROIMMUN AG, Lübeck, Germany (E. Lattwein); Utrecht University, Utrecht, the Netherlands (B.-J. Bosch); National Veterinary Institute, Uppsala, Sweden (S. Bornstein)
Main Article
Table 2
Antibodies against MERS-CoV in dromedary camels in 2 regions of Kenya, 2000*
Region |
County† |
Husbandry |
Sex |
Age |
No. samples positive by rELISA/no. tested (%) |
Eastern |
Marsabit |
Nomadic‡ |
F/M |
A |
24/42 (57.1) |
|
|
|
F/M |
J |
15/31 (48.4) |
Subtotal |
|
|
|
|
39/73 (53.4) |
Rift Valley |
Laikipia |
Ranch§ |
F/M |
A |
2/28 (7.1) |
|
|
|
F/M |
J |
0/28 (0) |
Subtotal |
|
|
|
|
2/56 (3.6) |
Total |
|
|
|
|
41/129 (31.8) |
Main Article
Page created: May 06, 2014
Page updated: May 06, 2014
Page reviewed: May 06, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.